Stryker Co. (NYSE:SYK) Shares Acquired by Great Lakes Retirement Inc.

Great Lakes Retirement Inc. boosted its position in Stryker Co. (NYSE:SYK) by 3.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,172 shares of the medical technology company’s stock after purchasing an additional 135 shares during the quarter. Great Lakes Retirement Inc.’s holdings in Stryker were worth $1,249,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Quarry LP bought a new stake in Stryker in the first quarter worth approximately $27,000. Freedom Wealth Alliance LLC bought a new stake in Stryker in the 4th quarter valued at $26,000. Rise Advisors LLC increased its holdings in Stryker by 692.9% in the 3rd quarter. Rise Advisors LLC now owns 111 shares of the medical technology company’s stock valued at $30,000 after buying an additional 97 shares during the period. West Tower Group LLC bought a new stake in shares of Stryker in the 2nd quarter worth about $35,000. Finally, Cornerstone Planning Group LLC bought a new stake in shares of Stryker in the 2nd quarter worth about $38,000. 77.09% of the stock is currently owned by institutional investors.

Insider Activity at Stryker

In other news, CAO William E. Berry, Jr. sold 7,690 shares of the company’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $358.48, for a total value of $2,756,711.20. Following the completion of the sale, the chief accounting officer now directly owns 3,675 shares of the company’s stock, valued at $1,317,414. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Stryker news, Director Ronda E. Stryker sold 201,146 shares of the firm’s stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $342.90, for a total transaction of $68,972,963.40. Following the completion of the transaction, the director now directly owns 3,755,128 shares in the company, valued at approximately $1,287,633,391.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO William E. Berry, Jr. sold 7,690 shares of the company’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $358.48, for a total transaction of $2,756,711.20. Following the completion of the sale, the chief accounting officer now directly owns 3,675 shares in the company, valued at approximately $1,317,414. The disclosure for this sale can be found here. Insiders have sold 212,109 shares of company stock valued at $72,845,768 in the last ninety days. Insiders own 5.90% of the company’s stock.

Stryker Stock Performance

Stryker stock traded down $0.36 during trading hours on Thursday, hitting $358.35. 520,427 shares of the stock traded hands, compared to its average volume of 1,314,837. Stryker Co. has a 1 year low of $249.98 and a 1 year high of $361.41. The stock has a market capitalization of $136.15 billion, a price-to-earnings ratio of 43.15, a P/E/G ratio of 2.86 and a beta of 0.89. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.58 and a quick ratio of 0.97. The firm’s 50 day moving average price is $342.51 and its 200-day moving average price is $305.23.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Tuesday, January 30th. The medical technology company reported $3.46 earnings per share for the quarter, beating the consensus estimate of $3.27 by $0.19. Stryker had a return on equity of 22.99% and a net margin of 15.44%. The company had revenue of $5.82 billion during the quarter, compared to analysts’ expectations of $5.60 billion. During the same period last year, the business earned $3.00 earnings per share. Stryker’s quarterly revenue was up 11.8% on a year-over-year basis. As a group, equities analysts expect that Stryker Co. will post 11.86 EPS for the current fiscal year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 30th. Investors of record on Friday, March 29th will be paid a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a yield of 0.89%. The ex-dividend date of this dividend is Wednesday, March 27th. Stryker’s payout ratio is 38.79%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on SYK shares. Canaccord Genuity Group raised Stryker from a “hold” rating to a “buy” rating and raised their price target for the company from $315.00 to $360.00 in a report on Wednesday, January 31st. Wells Fargo & Company boosted their price target on Stryker from $336.00 to $364.00 and gave the stock an “overweight” rating in a report on Wednesday, January 31st. Citigroup increased their target price on shares of Stryker from $340.00 to $362.00 and gave the company a “buy” rating in a research report on Wednesday, January 31st. Truist Financial increased their price target on Stryker from $330.00 to $345.00 and gave the stock a “hold” rating in a report on Wednesday, January 31st. Finally, Canaccord Genuity Group upgraded Stryker from a “hold” rating to a “buy” rating and set a $360.00 target price on the stock in a report on Wednesday, January 31st. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $331.52.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.